ISG posts healthy quarter, inks Philips deal
ISG Technologies recorded healthy gains in revenue during its first quarter, which is traditionally the software developer’s weakest revenue-generating period. Revenue grew 10%, while net income also climbed during the quarter (end-September).For
ISG Technologies recorded healthy gains in revenue during its first quarter, which is traditionally the software developers weakest revenue-generating period. Revenue grew 10%, while net income also climbed during the quarter (end-September).
For the period, the Mississauga, Ontario-based firm reported revenue of $5.8 million (U.S.), compared with $5.3 million last year. Net income grew to $187,000, compared with $5800 in 1997.
In other ISG news, the company has signed a 10-year software development agreement with Philips Medical Systems. ISG will supply the Shelton, CT-based company with various medical imaging products and custom engineering services. Specifically, ISG will continue to develop image viewing, image processing, and filming software for the primary console for the modality vendors Gyroscan NT MRI scanner. It will also provide ISG services for other Philips medical products in the future.
Philips, which has maintained a supply relationship with ISG since 1988, also recently signed an agreement to join the Surgical Navigation Network, a consortium of companies working to integrate image-guided surgery technology products. SNN companies have agreed to use the Windows NT-based image-guided surgery software system produced by Surgical Navigation Specialists, a joint venture between ISG and Carl Zeiss (SCAN 9/16/98).
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
